Skip to content
DataLookout
Menu

ACLNCT07185802

Clinical Outcome of Intra-articular Injection of PRP in ACL Injury.

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria shortened, about 5 words Show 8 more changesShow less
    • Trial completed
    • Interventions modified
    • Enrollment target: estimated 52 to confirmed 47
    • Primary completion date changed from estimate of Apr 2026 to Apr 5, 2026
    • Secondary endpoint revised
    • Study description expanded, about 2,913 words
    • Site details revised
    • Study title shortened, about 6 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Visual Analog Scale (VAS ): Change in pain intensity measured by Visual Analog Scale
Timeframe: Baseline, 3 weeks, 8 weeks, and 16 weeks after intervention.

Secondary (1)

Knee Injury and Osteoarthritis Outcome Score (KOOS): Change in functional outcome measured by Knee Injury and Osteoarthritis Outcome Score (KOOS)

Arms and interventions

Group A/Experimental groupExperimental

Will receive PRP and conventional conservative treatment (physical therapy, functional bracing, lifestyle modification)

Group B/Control groupActive comparator

Will receive conventional conservative treatment (physical therapy, functional bracing, lifestyle modification) only

Biologicals: PRP injection

Other: conventional conservative treatment (physical therapy, functional bracing, lifestyle modification)

Sites

1 site in 1 country

  • Bangabandhu Sheikh Mujib Medical UniversityDhaka, Bangladesh